Efficacy and tolerability of vildagliptin as add‐on therapy to metformin in Chinese patients with type 2 diabetes mellitus
Changyu Pan(University of Auckland), J. Lu(Chinese PLA General Hospital), Xiaoyi Lv(Fujian Medical University), Jianhua Ma(Nanjing Medical University), S.X Zheng(Second Hospital of Tianjin Medical University), Ping Han(China Medical University), Jinhui Liu(Nanjing Medical University), Xiaoping Xing(Chinese Academy of Medical Sciences & Peking Union Medical College), Giovanni Bader(Novartis (Switzerland))
Cited by 80
Related Papers
Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes
|New England Journal of Medicine|2008|7.4k
Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis
|Computers in Biology and Medicine|2022|183
Serum Raman spectroscopy combined with convolutional neural network for rapid diagnosis of HER2-positive and triple-negative breast cancer
|Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy|2022|156
Epidemiology of Type 2 Diabetic Foot Problems and Predictive Factors for Amputation in China
|The International Journal of Lower Extremity Wounds|2015|153